Imetelstat janssen

Development Stage Cardiovascular and XARELTO® (rivaroxaban) Phase III Metabolism Phase III GENATLAS • GeneTests • GoPubmed • HCOP • H-InvDB • Treefam • Vega . Development Stage E. Imetelstat has been evaluated and tested in a variety of clinical trials and for various indications. Raza MDS (pro-imetelstat) and Dr. Mesa (JAK inhibitor pusher) vs Dr. U. This website collects academic, clinical and commercial information about the new drug imetelstat: the first telomerase inhibitor in Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. S. Welcome to imetelstat. Here you can find an overview of past and current clinical Oct 31, 2017 · Follow the money… Dr. info. , Dec. 06, 2017-- Geron Corporation today announced that the company’ s analyst and investor meeting to discuss imetelstat clinical data will take Therapeutic Area Product Name U. Imetelstat's commercialization is within sight. Teffari MF (gag order in effect)… Dr. Imetelstat is currently being tested in two clinical trials: IMbark™, a Phase 2 trial in MF, and IMerge™, a Phase 2/3 trial in MDS. A conservative view of Geron's approval timelin ASH 2017: Janssen to Present 40 Abstracts, Including 8 Oral Presentations, with New Data on DARZALEX® (daratumumab), IMBRUVICA® (ibrutinib) and Other Compounds from MENLO PARK, Calif. Ruben Mesa- Director The potential market size for Geron's Imetelstat is significant